"The claim that pemetrexed is superior in adenocarcinoma is one that is not supported by the US FDA [US Food and Drug Administration] and is not supported by a careful consideration of the ...

A randomized, phase 2 trial of carboplatin plus pemetrexed (Alimta, Eli Lilly) with or without pembrolizumab showed significantly better rates of response and longer progression-free survival with ...

The addition of pemetrexed plus platinum chemotherapy to the immune checkpoint inhibitor pembrolizumab showed manageable toxicity among patients with metastatic nonsquamous non-small cell lung ...

Pemetrexed and cisplatin is the name of a chemotherapy drug combination. It includes the drugs we list below, next to each drug we have how you pronounce the drug name in brackets. pemetrexed (peh-meh ...

Introduction: Malignant pleural mesothelioma (MPM) is a rapidly progressive tumor that is increasing in frequency worldwide. Treatment options are limited, and response to chemotherapy is poor.

There were no grade 3 or greater hemorrhagic events or hypertension cases. More recently, a phase III study showed noninferiority between first-line pemetrexed plus cisplatin and gemcitabine plus ...

Patients were randomly assigned (2:1) to receive pemetrexed and platinum plus pembrolizumab (n = 410) or placebo (n = 206) every 3 weeks for 4 cycles, then pemetrexed maintenance plus pembrolizumab or ...

A single RCT of pemetrexed in MPM was identified. The EMPHACIS ('Evaluation of mesothelioma in a Phase III trial of pemetrexed with cisplatin') study compared pemetrexed plus cisplatin with cisplatin ...

Pemetrexed and carboplatin is the name of a chemotherapy combination. It includes the drugs we list below, next to each drug we have how you pronounce the drug name in brackets. You have pemetrexed ...

Phase 3 PAPILLON study showed RYBREVANT ® in combination with carboplatin and pemetrexed significantly improved progression-free survival, reducing the risk of disease progression or death by 60 ...